Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Siguldas Pagasts

7 clinical trials in Siguldas Pagasts, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Siguldas Pagasts at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Siguldas Pagasts

Open in trial search
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LatviaLatvia
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
  • Sponsor:Neurocrine Biosciences Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
  • Sponsor:Neurocrine Biosciences Inc.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Curateq Biologics Private Limited

Other cities in Latvia

The busiest research cities in the country

All 19 cities in Latvia

Clinical research in Siguldas Pagasts

What the registry says about research in the country

01 Bone Health Research

Innovative clinical research focusing on post-menopausal osteoporosis treatment evaluation, examining the effectiveness and safety of novel therapeutic approaches to improve bone mineral density.

  • Bone Density Management
  • Therapeutic Equivalence Studies
  • Biomarker Analysis

Studies incorporate comprehensive assessment of pharmacodynamics and immunogenicity profiles in treatment outcomes.

02 Cardiovascular Studies

Advanced research into atrial fibrillation management, specifically targeting high-risk patients who cannot use conventional oral anticoagulation treatments.

  • Stroke Prevention
  • Alternative Anticoagulation Therapies
  • High-Risk Patient Care

These trials aim to evaluate new therapeutic options for reducing systemic embolism and ischemic stroke risks in vulnerable populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.